IFU
JAZZ icon

iSAM Funds (UK)’s Jazz Pharmaceuticals JAZZ Stock Holding History

iSAM Funds (UK)’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-2,233
Closed -$237K – 725
2025
Q2 		$237K Buy
+2,233
New +$243K 0.05% 398
2023
Q3 		– Sell
-2,488
Closed -$308K – 284
2023
Q2 		$308K Buy
+2,488
New +$335K 0.28% 139

Other funds holding JAZZ

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

iSAM Funds (UK)'s JAZZ Position: Q3 2025 in Review

iSAM Funds (UK) sold out of Jazz Pharmaceuticals (JAZZ) in Q3 2025, closing a stake of 2,233 shares — an estimated $237K sold.

iSAM Funds (UK) first reported a position in JAZZ in Q2 2023 and held it in 2 quarters. The position peaked at $308K in Q2 2023. 503 funds tracked by Wall St. Rank hold JAZZ as of Q3 2025.

  • iSAM Funds (UK) reported no remaining Jazz Pharmaceuticals position as of Q3 2025 after selling out during the quarter.
  • iSAM Funds (UK) sold 2,233 Jazz Pharmaceuticals shares in Q3 2025, an estimated $237K.
  • iSAM Funds (UK) first reported a position in Jazz Pharmaceuticals in Q2 2023 and held it in 2 quarters.
  • iSAM Funds (UK)'s Jazz Pharmaceuticals position peaked at $308K in Q2 2023.
  • 503 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q3 2025.

Based on iSAM Funds (UK)'s 13F filing for Q3 2025, filed 14 Nov 2025.